Li-Kuo Su, Editor-in-Chief of Cancer Cell will join us at the Hotel Alimara, Monday 14 January 2013, 09:00 – 10:15, to deliver the 5th in VHIO´s prestigious series of VHIO Meet the Editors talks:
Cancer Cell and the Cancer Research Community
Related Posts
VHIO tests a new combination of drugs for HER2-positive breast cancer without the adverse effects of conventional chemotherapy
This research studied the action mechanisms of two drugs—lapatinib and trastuzumab—in combination for the treatment of HER2-positive breast cancer. Lapatinib is a molecule which, when combined with trastuzumab, neutralizes the activity of the HER2 receptor and improves the effect of the antibody
07 Sep 2010
Oncology channel ecancerTV catches up in Chicago with VHIO´s Rodrigo Dienstmann and Enriqueta Felip
During this year´s Annual Meeting of the American Society of Clinical Oncology (ASCO), that came to a close yesterday in…
08 Jun 2017
WIN Consortium and Pfizer Collaborate to Advance Personalized Cancer Care
The Worldwide Innovative Network (WIN) in personalized cancer medicine consortium, of which the Vall d´Hebron Institute of Oncology (VHIO) is…
17 Dec 2012
A new treatment, fresh hope and future horizons for metastatic breast cancer patients in Spain
Officially announced today, Halaven ® (Eribulin) has received reimbursement approval from the Spanish Directorate General of Pharmacy and Health Products,…
05 Sep 2013
The 2013 Georges Mathé Prize awards innovative research into brain tumors
The Prize, supporting translational research of excellence, was established in memory of the pioneer of cancer research in France, Georges…
14 Oct 2013
BIB launches portal to promote Catalan bioinformatics platform
Bioinformatics Barcelona (BIB), launched in 2014, constitutes a regionally-based multi-center bioinformatics platform as part of a joint initiative of the…
15 Jun 2016
Date in the diary with Nature Reviews Cancer 29 June 15:00h – 16:15h
Taking place on Monday 29 June 2015, 15:00 – 16:15, we are delighted to announce that Senior Editor of Nature Reviews Cancer,…
15 Jun 2015
Genomic study leads to classification of fibroepithelial breast cancer and predicts tumor cell behavior
The study, led by VHIO, is the first to use gene expression to classify fibroepithelial tumors Genomic discovery reveals decisively…
18 Mar 2015
Immunotherapy shown to be effective against metastatic bladder cancer
Clinical research carried out as a phase I study shows that immunotherapy is safe and effective in reducing the size…
27 Nov 2014
A giant little step in cancer treatment opening up new therapeutic horizons
A study by the Vall d’Hebron Institute of Oncology (VHIO) demonstrates that by combining drugs which had already been used previously, but became ineffective, they boost each other’s efficacy and at the same time overcome the resistance developed by the patient to each individual drug. This strategy could offer an unprecedented key to multiplying treatment options.
28 Feb 2012
ecancerTV/SABCS 2015 interview: Javier Cortes discusses efficacy and gene expression results from eribulin neoadjuvant study
At the recent annual San Antonio Breast Cancer Symposium (SABCS), 8 – 12 December, San Antonio, USA, the ecancerTV team…
04 Jan 2016
VHIO co-hosts study visit for scientific journalists across Europe
A special study visit was jointly organized by the Centre of Genomic Regulation (CRG) and the European Molecular Biology Laboratory (EMBL) as partners of the EU CommHERE Communicating European Health Research Network, in collaboration with the European Union of Science Journalists’ Associations (EUSJA)
23 May 2014
Spanish periodical EL MUNDO reveals its top 25 of the most influential Spanish Citizens in Medicine for 2014
Each year, in January, the Spanish periodical EL MUNDO publishes its selection of the 500 most influential Spanish citizens for that…
10 Jan 2014
ecancer catches up with Josep Tabernero on exploring new targets in GI cancer as well as the WIN Consortium launch of WINTHER, an original academic and international clinical trial
In two recent interviews with ecancer Josep Tabernero highlights key studies and promising data presented at the ESMO 14th World Congress on Gastrointestinal Cancer (WCGC), Barcelona, 27 – 30 June 2012, as well as discusses the WIN Consortium (Worldwide Innovative Networking in personalized cancer medicine) launch of WINTHER: The WIN therapeutics clinical trial.
31 Jul 2012
